IL17A and neoplasm: Given that MIF can influence either pro- or anti-inflammatory phenotypes in other cell types depending on the type and severity of disease, further studies into whether, and if so how, MIF controls variable γδ T cell functions (i.e. via specific induction of either IFN-y, IL-17 and/or PD-L1) in models of tumor progression are needed.